Genpact Limited Files 8-K on Financials
Ticker: G · Form: 8-K · Filed: Feb 6, 2025 · CIK: 1398659
| Field | Detail |
|---|---|
| Company | Genpact LTD (G) |
| Form Type | 8-K |
| Filed Date | Feb 6, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
TL;DR
Genpact dropped an 8-K on Feb 6th covering financials. Check it out.
AI Summary
Genpact Limited filed an 8-K on February 6, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to its business operations. The company is incorporated in Bermuda and its principal executive offices are located in Hamilton.
Why It Matters
This filing provides investors with updated information on Genpact's financial performance and condition, which can influence investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any unusual risks or events.
Key Players & Entities
- Genpact Limited (company) — Registrant
- February 6, 2025 (date) — Date of earliest event reported
- Bermuda (location) — State of incorporation
- Hamilton (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Genpact Limited's results of operations and financial condition, and to include financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on February 6, 2025.
Where is Genpact Limited incorporated?
Genpact Limited is incorporated in Bermuda.
What is the address of Genpact Limited's principal executive offices?
The address of Genpact Limited's principal executive offices is Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda.
What is the SEC file number for Genpact Limited?
The SEC file number for Genpact Limited is 001-33626.
Filing Stats: 584 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2025-02-06 16:12:21
Key Financial Figures
- $0.01 — ch registered Common shares, par value $0.01 per share G New York Stock Exchange I
Filing Documents
- g-20250206.htm (8-K) — 30KB
- genpactltdexhibit991q424.htm (EX-99.1) — 349KB
- imagea.jpg (GRAPHIC) — 8KB
- 0001398659-25-000025.txt ( ) — 540KB
- g-20250206.xsd (EX-101.SCH) — 2KB
- g-20250206_lab.xml (EX-101.LAB) — 22KB
- g-20250206_pre.xml (EX-101.PRE) — 13KB
- g-20250206_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On February 6, 2025, Genpact Limited (the "Company") issued a press release announcing its financial results for the fourth quarter and full year ended December 31, 2024. The Company is furnishing this Form 8-K pursuant to Item 2.02, "Results of Operations and Financial Condition." A copy of the press release, attached hereto as Exhibit 99.1 , is incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The Company is making reference to non-GAAP financial information in the press release and on the conference call. A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures is contained in the attached press release.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit 99.1 Press release dated February 6, 2025 Exhibit 104 C over Page Interactive Data File (embedded within the Inline XBRL document) Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENPACT LIMITED Date: February 6, 2025 By: /s/ Heather D. White Name: Heather D. White Title: Senior Vice President, Chief Legal Officer and Secretary